Competition Board Decision On Price Discrimination

The Competition Board decided not to initiate an investigation concerning the Complaint of Emek Ecza Deposu for Abuse of Dominance by 15 Pharmaceutical Companies through Price Discrimination

Update: The Competition Board concluded the preliminary investigation initiated after annulment of its decision dated 21.04.2011 and numbered 11-25 / 470-141 by the 13th Chamber of Council of State and decided that the companies subject of the complaint did not conducted any abusive behaviour.

Background

Emek Ecza Deposu İlaç ve Kimyevi Maddeler Itriyat İth. İhr. ve Tic. A.Ş. ("Emek Warehouse") filed a complaint on 29.12.2010 against 15 different pharmaceutical companies alleging that those companies did not provide the same opportunities such as discounts, surplus goods, exit premiums and periodical premiums to Emek Warehouse and other warehouses, in other words they made a discrimination between Emek Warehouse and other warehouses and thus abused their dominant positions;